Clinical Performance of the Point | 合法醫療器材資訊網

The cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas Liat System is a multiplex real-time polymerase chain reaction (PCR) test that ... Read More

The innovative cobas® Liat® System brings accurate and reliable PCR results right to ... Detect and differentiate SARS-CoV-2, influenza A and influenza B in 20​ ... Read More

The cobas® SARS-CoV-2 Test is a single-well dual target assay, which includes both specific detection of SARS-CoV-2 and pan-Sarbecovirus detection for the ... Read More

2020年7月24日 — 2. COVID-19 Detection: 1. Viral RNA detection (PCR-based). 2. ... Roche cobas® SARS-CoV-2. Test. Qiagen. NeuMoDx™ 96/288 Molecular ... Read More

2020年5月11日 — Nucleic acid test for use on the cobas® Liat® System ... SARS-CoV-2, influenza A virus, and influenza B virus nucleic acids in clinical specimens and is ... produce the expected results, contact your local Roche representative. Read More

2020年9月14日 — cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas Liat System. Company: Roche Molecular Systems, Inc. Indication:. Read More

2021年3月12日 — cobas SARS-CoV-2 & Influenza Test for use on cobas Liat System-Letter to Clinical Laboratory Staff, Point-of-Care Facility Staff, and Health Care ... Read More

由 G Hansen 著作 · 被引用 11 次 — Using Liat, positive percent agreement for SARS-CoV-2 was 100% (162/162) and the negative percent agreement was 97.4% (190/195). The Liat is an RT-​PCR ... Read More

由 G Hansen 著作 · 被引用 11 次 — The Liat is an RT-PCR POC test that provides highly accurate SARS-CoV-2 results in 20 min with performance equivalent to that of high- ... Read More